Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07139860

Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction

The goal of this observational study is to learn about the effectiveness of an artificial intelligence-based early warning system for predicting adverse events in patients with acute myocardial infarction (AMI). The main question it aims to answer is:

Does an AI-based early warning system improve the assessment and prediction of adverse events across the full course of AMI care (from prevention to diagnosis, treatment, and rehabilitation)?

Participants who are receiving routine medical care for AMI in tertiary hospitals will have their multimodal medical data (clinical records, diagnostic tests, imaging, treatment pathways) collected and analyzed. Data will be integrated using innovative cross-modal representation methods and predictive models. The study will follow patients during their hospital stay and subsequent clinical follow-up to evaluate the feasibility, accuracy, and clinical value of the AI-based early warning system.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acute Myocardial Infarction With ST Elevation Cardiovascular Diseases Early Warning Heart Diseases Infarction Intelligent Management Platform Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms ST Elevation Myocardial Infarction Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Hospitalized patients who meet the diagnostic criteria for acute myocardial infarction. 2. Patients who agree to participate and sign the informed consent form.

Exclusion criteria

  • 1. Patients with terminal malignant tumors and an expected survival time of less than 3 months. 2. Patients with complete disability and inability to communicate. 3. Patients unable to comply with follow-up.

Treatment and study plan

Primary outcomes

  1. MACCE

    Time frame: 1-3 years

    Cardiac death

    All-cause mortality

    Malignant arrhythmia

    Non-fatal recurrent myocardial infarction

    Non-fatal stroke

    Unplanned repeat revascularization

    Rehospitalization for heart failure

Study contacts

Contact information is provided by the study sponsor or research team.

Hui Chen

CONTACT

[email protected]

+86 13910710028

Sponsors and collaborators

Lead sponsor

Hui Chen

Other

Registry information

Acronym: AIEWAEAMI

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Aug 24, 2025
Registry last updated
Aug 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.